This is an article the I would trot out if anyone tried to argue that a Data Safety and Monitoring Board should
- like the investigators
- be blinded as to treatment status during their deliberations.
BRADLEY D. FREEMAN
- ROBERT L. DANNER
- STEVEN M. BANKS
- and CHARLES NATANSON “Safeguarding Patients in Clinical Trials with High Mortality Rates”
- American Journal of Respiratory and Critical Care Medicine
- Vol. 164
- No. 2 (2001)
- pp. 190-192. doi: 10.1164/ajrccm.164.2.2011028. Available at http://www.atsjournals.org/doi/full/10.1164/ajrccm.164.2.2011028.